DK1960370T3 - Pyridazinonderivater til tumorbehandling - Google Patents
Pyridazinonderivater til tumorbehandlingInfo
- Publication number
- DK1960370T3 DK1960370T3 DK06806700.8T DK06806700T DK1960370T3 DK 1960370 T3 DK1960370 T3 DK 1960370T3 DK 06806700 T DK06806700 T DK 06806700T DK 1960370 T3 DK1960370 T3 DK 1960370T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumor treatment
- pyridazinone derivatives
- pyridazinone
- derivatives
- tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005057924A DE102005057924A1 (de) | 2005-12-05 | 2005-12-05 | Pyridazinonderivate |
PCT/EP2006/010668 WO2007065518A1 (de) | 2005-12-05 | 2006-11-07 | Pyridiazinonderivate zur behandlung von tumoren |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1960370T3 true DK1960370T3 (da) | 2012-01-02 |
Family
ID=37775213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06806700.8T DK1960370T3 (da) | 2005-12-05 | 2006-11-07 | Pyridazinonderivater til tumorbehandling |
Country Status (28)
Country | Link |
---|---|
US (1) | US8173653B2 (da) |
EP (1) | EP1960370B1 (da) |
JP (1) | JP5210172B2 (da) |
KR (1) | KR101367447B1 (da) |
CN (1) | CN101326167B (da) |
AR (1) | AR057214A1 (da) |
AT (1) | ATE527241T1 (da) |
AU (1) | AU2006322364B2 (da) |
BR (1) | BRPI0619407A2 (da) |
CA (1) | CA2632217C (da) |
CY (1) | CY1112206T1 (da) |
DE (1) | DE102005057924A1 (da) |
DK (1) | DK1960370T3 (da) |
EA (1) | EA014667B1 (da) |
EC (1) | ECSP088598A (da) |
ES (1) | ES2373117T3 (da) |
HK (1) | HK1127489A1 (da) |
IL (1) | IL191832A (da) |
MY (1) | MY153261A (da) |
NZ (1) | NZ569568A (da) |
PE (1) | PE20070832A1 (da) |
PL (1) | PL1960370T3 (da) |
PT (1) | PT1960370E (da) |
SI (1) | SI1960370T1 (da) |
TW (1) | TWI395741B (da) |
UA (1) | UA95934C2 (da) |
WO (1) | WO2007065518A1 (da) |
ZA (1) | ZA200805877B (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2397283T3 (es) * | 2006-07-25 | 2013-03-06 | Cephalon, Inc. | Derivados de piridizinona |
DE102006037478A1 (de) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | 2-(Heterocyclylbenzyl)-pyridazinonderivate |
CN101636386A (zh) * | 2006-12-14 | 2010-01-27 | 安斯泰来制药有限公司 | 用作crth2拮抗剂和抗过敏剂的多环酸化合物 |
BRPI0809498A2 (pt) * | 2007-04-02 | 2014-09-23 | Inst Oneworld Health | Compostos inibidores de cftr e seus usos |
DE102007025718A1 (de) * | 2007-06-01 | 2008-12-04 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007025717A1 (de) * | 2007-06-01 | 2008-12-11 | Merck Patent Gmbh | Arylether-pyridazinonderivate |
DE102007026341A1 (de) | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
DE102007032507A1 (de) | 2007-07-12 | 2009-04-02 | Merck Patent Gmbh | Pyridazinonderivate |
DE102007038957A1 (de) * | 2007-08-17 | 2009-02-19 | Merck Patent Gmbh | 6-Thioxo-pyridazinderivate |
DE102007061963A1 (de) * | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
CN101538245B (zh) * | 2008-03-18 | 2011-02-16 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物及其制备方法和制备药物的用途 |
DE102008019907A1 (de) * | 2008-04-21 | 2009-10-22 | Merck Patent Gmbh | Pyridazinonderivate |
DE102008028905A1 (de) | 2008-06-18 | 2009-12-24 | Merck Patent Gmbh | 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate |
DE102008037790A1 (de) | 2008-08-14 | 2010-02-18 | Merck Patent Gmbh | Bicyclische Triazolderivate |
EP2361250B1 (en) * | 2008-12-22 | 2013-08-07 | Merck Patent GmbH | Novel polymorphic forms of 6-(1-methyl-1h-pyrazol-4-yl)-2-{3-[5-(2-morpholin-4-yl-ethoxy)-pyrimidin-2-yl]-benzyl}-2h-pyridazin-3-one dihydrogenphosphate and processes of manufacturing thereof |
DE102008062826A1 (de) | 2008-12-23 | 2010-07-01 | Merck Patent Gmbh | Pyridazinonderivate |
DE102009003954A1 (de) | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Pyridazinonderivate |
DE102009004061A1 (de) * | 2009-01-08 | 2010-07-15 | Merck Patent Gmbh | Pyridazinonderivate |
KR101829595B1 (ko) | 2009-01-08 | 2018-02-14 | 메르크 파텐트 게엠베하 | 3-(1-{3-[5-(1-메틸-피페리딘-4일메톡시)-피리미딘-2-일]-벤질}-6-옥소-1,6-디히드로-피리다진-3-일)-벤조니트릴 히드로클로라이드 염의 신규한 다형체 및 이의 제조 방법 |
CN102731409A (zh) * | 2011-04-08 | 2012-10-17 | 中国科学院上海药物研究所 | 一类哒嗪酮类化合物,其药物组合物、制备方法及用途 |
KR101842645B1 (ko) * | 2012-04-12 | 2018-03-29 | 한국화학연구원 | 신규한 히드라진온이 치환된 피리미딘 유도체 및 그의 용도 |
PT2914264T (pt) * | 2012-11-02 | 2017-11-14 | Merck Patent Gmbh | Derivado 6-oxo-1,6-di-hidro-piridazina para utilização no tratamento de carcinoma hepatocelular (hcc) |
FI3640241T3 (fi) | 2013-10-18 | 2023-01-13 | Bromodomeeni-inhibiittorit | |
CN103772352B (zh) * | 2014-01-16 | 2017-01-18 | 四川百利药业有限责任公司 | 哒嗪酮类衍生物及其制备方法和用途 |
US10231972B2 (en) * | 2014-12-11 | 2019-03-19 | Merck Patent Gmbh | Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a quinazoline derivative |
EP3532467A1 (en) * | 2016-10-26 | 2019-09-04 | Proteostasis Therapeutics, Inc. | Pyridazine derivatives, compositions and methods for modulating cftr |
CN107334767B (zh) * | 2017-06-08 | 2019-03-05 | 中国医学科学院医药生物技术研究所 | 一种哒嗪酮类化合物在肿瘤治疗中的应用 |
WO2019043217A1 (en) | 2017-09-04 | 2019-03-07 | F. Hoffmann-La Roche Ag | DIHYDROBENZIMIDAZOLONES |
JP7162132B2 (ja) | 2018-11-06 | 2022-10-27 | エッジワイズ セラピューティクス, インコーポレイテッド | ピリダジノン化合物およびその使用 |
CA3118904A1 (en) * | 2018-11-06 | 2020-05-14 | Edgewise Therapeutics, Inc. | Pyridazinone compounds and uses thereof |
CN113272014A (zh) | 2018-11-06 | 2021-08-17 | 艾知怀斯治疗学公司 | 哒嗪酮化合物及其用途 |
EP3935050A4 (en) | 2019-03-06 | 2023-01-04 | C4 Therapeutics, Inc. | HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RO79566A2 (ro) * | 1980-05-28 | 1982-08-17 | Institutul De Cercetari Chimico-Farmaceutice,Ro | Substante din clasa 2-(3'-aril-piridazonil-1'5-metil-5-aril-(alchil)amino-tiadiazolului |
RO79562A2 (ro) * | 1980-05-29 | 1982-08-17 | Institutul De Cercetari Chimico-Farmaceutice,Ro | Substante din clasa 3-(3'-aril-piridazonil-1'5-metil-4-aril(alchil)-5-mercapto-1,2,4-triazolului si procedeu de obtinere a acestora |
JPS5826802A (ja) * | 1981-08-10 | 1983-02-17 | Sankyo Co Ltd | 農園芸用殺菌剤 |
DE3321012A1 (de) * | 1983-06-10 | 1984-12-13 | A. Nattermann & Cie GmbH, 5000 Köln | Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung |
KR100204381B1 (ko) * | 1990-09-21 | 1999-06-15 | 마크 에스. 아들러 | 디히드로피리다지논, 피리다지논 화합물, 그들을 함유하는 조성물 및 그들의 용법 |
EP0478195B1 (en) * | 1990-09-21 | 1999-05-26 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones as fungicides |
AU691673B2 (en) * | 1994-11-14 | 1998-05-21 | Dow Agrosciences Llc | Pyridazinones and their use as fungicides |
US6121251A (en) * | 1996-10-11 | 2000-09-19 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides |
WO1999010332A1 (en) * | 1997-08-22 | 1999-03-04 | Abbott Laboratories | Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
ES2324126T3 (es) * | 1997-11-19 | 2009-07-30 | Kowa Co., Ltd. | Derivados de piridazina y medicamentos que los contienen como ingrediente activo. |
US7060822B1 (en) * | 1999-07-30 | 2006-06-13 | Abbott Gmbh & Co. Kg | 2-pyrazolin-5-ones |
HUP0400540A3 (en) | 1999-07-30 | 2004-09-28 | Abbott Gmbh & Co Kg | 2-pyrazolin-5-one derivatives, their use and pharmaceutical compositions containing them |
AUPR606401A0 (en) * | 2001-07-02 | 2001-07-26 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof |
EP1463509A1 (en) * | 2001-10-31 | 2004-10-06 | MERCK PATENT GmbH | Type 4 phosphodiesterase inhibitors and uses thereof |
US20040142932A1 (en) * | 2002-01-18 | 2004-07-22 | Michael Hepperle | Substituted pyridazinones |
WO2004022540A2 (en) * | 2002-09-06 | 2004-03-18 | Fujisawa Pharmaceutical Co., Ltd. | Pyridazinone and pyridone derivatives as adenosine antagonists |
MXPA05009500A (es) * | 2003-03-07 | 2005-10-18 | Kowa Co | Derivado de benzofurano. |
WO2004100960A2 (en) * | 2003-04-25 | 2004-11-25 | Gilead Sciences, Inc. | Anti-inflammatory phosphonate compounds |
CN101410120A (zh) * | 2003-04-25 | 2009-04-15 | 吉里德科学公司 | 抗炎的膦酸酯化合物 |
US7763617B2 (en) * | 2005-03-07 | 2010-07-27 | Kyorin Pharmaceutical Co., Ltd. | Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient |
-
2005
- 2005-12-05 DE DE102005057924A patent/DE102005057924A1/de not_active Withdrawn
-
2006
- 2006-11-07 CN CN2006800458935A patent/CN101326167B/zh active Active
- 2006-11-07 MY MYPI20081936A patent/MY153261A/en unknown
- 2006-11-07 EP EP06806700A patent/EP1960370B1/de active Active
- 2006-11-07 BR BRPI0619407-9A patent/BRPI0619407A2/pt not_active Application Discontinuation
- 2006-11-07 DK DK06806700.8T patent/DK1960370T3/da active
- 2006-11-07 PT PT06806700T patent/PT1960370E/pt unknown
- 2006-11-07 AU AU2006322364A patent/AU2006322364B2/en not_active Ceased
- 2006-11-07 PL PL06806700T patent/PL1960370T3/pl unknown
- 2006-11-07 CA CA2632217A patent/CA2632217C/en active Active
- 2006-11-07 SI SI200631187T patent/SI1960370T1/sl unknown
- 2006-11-07 ES ES06806700T patent/ES2373117T3/es active Active
- 2006-11-07 NZ NZ569568A patent/NZ569568A/en not_active IP Right Cessation
- 2006-11-07 UA UAA200808757A patent/UA95934C2/ru unknown
- 2006-11-07 AT AT06806700T patent/ATE527241T1/de active
- 2006-11-07 JP JP2008543675A patent/JP5210172B2/ja not_active Expired - Fee Related
- 2006-11-07 EA EA200801428A patent/EA014667B1/ru not_active IP Right Cessation
- 2006-11-07 US US12/096,079 patent/US8173653B2/en active Active
- 2006-11-07 WO PCT/EP2006/010668 patent/WO2007065518A1/de active Application Filing
- 2006-11-07 KR KR1020087016217A patent/KR101367447B1/ko active IP Right Grant
- 2006-12-01 AR ARP060105310A patent/AR057214A1/es active IP Right Grant
- 2006-12-04 TW TW095145046A patent/TWI395741B/zh not_active IP Right Cessation
- 2006-12-05 PE PE2006001553A patent/PE20070832A1/es active IP Right Grant
-
2008
- 2008-05-29 IL IL191832A patent/IL191832A/en active IP Right Grant
- 2008-07-02 EC EC2008008598A patent/ECSP088598A/es unknown
- 2008-07-04 ZA ZA200805877A patent/ZA200805877B/xx unknown
-
2009
- 2009-06-09 HK HK09105156.0A patent/HK1127489A1/xx not_active IP Right Cessation
-
2011
- 2011-12-14 CY CY20111101245T patent/CY1112206T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1960370T3 (da) | Pyridazinonderivater til tumorbehandling | |
DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
ATE525088T1 (de) | Kombinationstherapie | |
ATE520670T1 (de) | Pyridazinderivate | |
NL1029015A1 (nl) | Therapeutische verbindingen. | |
DE602006004866D1 (de) | Katheter | |
DK1765391T3 (da) | Bakterielle præparater til behandlingen af cancer | |
DK1879623T3 (da) | Genterapi til rygmarvssygdomme | |
SMP200900085B (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative. | |
DK2426106T3 (da) | Piperidin- og piperazinderivat til behandling af tumorer | |
DK3567035T3 (da) | N-substituerede 2,5-dioxo-azolin-forbindelser til anvendelse ved behandling af cancer | |
IL188430A0 (en) | Treatment of tumors | |
DK2195015T3 (da) | Sammensætning til behandling af prostatacancer | |
DK2121139T3 (da) | Formulations for cancer treatment | |
NO20070251A (no) | Brønnbehandling | |
NO20070297A (no) | Brønnbehandling | |
DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
DK1863899T3 (da) | Hudbehandlingspræparater | |
DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
DE602006019395D1 (de) | Media-behandlungseinrichtung | |
FR2872704B1 (fr) | Pluritherapie contre le cancer | |
DE602006013094D1 (de) | Krebsmittel | |
DK2147122T3 (da) | Enzymatisk kræftbehandling | |
EP1885384A4 (en) | TREATMENT OF LIVER DISEASES | |
GB0517387D0 (en) | Combinations for the treatment of cancer |